Skip to main content

FRX · Fennec Pharmaceuticals Inc. · Documents

13.2900 CAD -1.1700 (-8.09%) At close · Nov 5 Intraday price with Plus

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

2025
Mar 26
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $47.54M ▲ 123.7% Net loss $436K Diluted EPS -$0.02
Mar 26
Report SEDAR+
MD&A
2024
Nov 12
Report SEDAR+
MD&A
Aug 13
Report SEDAR+
MD&A
May 14
Quarterly report 10-Q FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $25.38M ▲ 1413.2% Net income $12.84M Diluted EPS $0.41
May 14
Report SEDAR+
MD&A
Showing 101–150 of 527 documents